A series of studies have shown that targeting RAS, WNT, and PIK3 signaling pathways and angiogenesis are potential strategies to enhance the efficacy of cancer therapy (Verret et al., 2019; Xu et al., 2020). The gene discussed is PIK3CG; the disease is cancer.